Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres
- PMID: 15315526
- DOI: 10.1111/j.1468-2982.2004.00741.x
Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres
Abstract
Aim of this study was to determine whether menstrual attacks differ from nonmenstrual attacks (NMA) as regards clinical features or response to abortive treatment in women affected by menstrually related migraine (MRM) referred to tertiary care centres. Sixty-four women with MRM were enrolled in a 2-month diary study. Perimenstrual attacks were split into three groups--premenstrual (PMA), menstrual (MA) and late menstrual (LMA)--and compared to nonmenstrual ones. Perimenstrual attacks were significantly longer than NMA. No other migraine attack features were found to differ between the various phases of the cycle. Migraine work-related disability was significantly greater in PMA and MA than in NMA. Acute attack treatment was less effective in perimenstrual attacks. Pain-free at 2 h after dosage was achieved in 13.5% of MA (OR 0.41; 95% CI 0.22, 0.76) vs. 32.9% of NMA. We concluded that, in MRM, perimenstrual attacks are longer and less responsive to acute attack treatment than NMA.
Copyright 2004 Blackwell Publishing Ltd
Similar articles
-
Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine.Cephalalgia. 2010 Oct;30(10):1187-94. doi: 10.1177/0333102409359315. Epub 2010 Mar 31. Cephalalgia. 2010. PMID: 20855364
-
Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.Neurology. 2021 Oct 26;97(17):e1661-e1671. doi: 10.1212/WNL.0000000000012723. Epub 2021 Sep 7. Neurology. 2021. PMID: 34493613 Free PMC article.
-
Lack of seasonal variation in menstrually-related migraine.Cephalalgia. 2008 Dec;28(12):1277-81. doi: 10.1111/j.1468-2982.2008.01676.x. Epub 2008 Aug 22. Cephalalgia. 2008. PMID: 18727637
-
Menstrual migraine: clinical and therapeutical aspects.Expert Rev Neurother. 2007 Sep;7(9):1105-20. doi: 10.1586/14737175.7.9.1105. Expert Rev Neurother. 2007. PMID: 17868010 Review.
-
Menstrually related migraine: breaking the cycle in your clinical practice.J Reprod Med. 2007 Oct;52(10):888-95. J Reprod Med. 2007. PMID: 17977161 Review.
Cited by
-
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine.Ther Clin Risk Manag. 2006 Sep;2(3):303-8. doi: 10.2147/tcrm.2006.2.3.303. Ther Clin Risk Manag. 2006. PMID: 18360605 Free PMC article.
-
Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial.Cephalalgia. 2015 Jan;35(1):45-50. doi: 10.1177/0333102414542290. Epub 2014 Jul 22. Cephalalgia. 2015. PMID: 25053749 Free PMC article. Clinical Trial.
-
Estrogen, migraine, and vascular risk.Neurol Sci. 2018 Jun;39(Suppl 1):11-20. doi: 10.1007/s10072-018-3333-2. Neurol Sci. 2018. PMID: 29904828 Review.
-
Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.J Headache Pain. 2017 Aug 25;18(1):91. doi: 10.1186/s10194-017-0801-7. J Headache Pain. 2017. PMID: 28842849 Free PMC article.
-
Migraine in postmenopausal women and the risk of invasive breast cancer.Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3116-22. doi: 10.1158/1055-9965.EPI-08-0527. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990752 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical